National Academy of Medicine held workshop on "tackling issues of access and hesitancy" on vaccines in August - COVID and vaccine confidence were keynote speeches
https://www.nationalacademies.org/event/05-28-2020/the-critical-public-health-value-of-vaccines-tackling-issues-of-access-and-hesitancy-a-workshop
https://www.youtube.com/watch?v=rjWp9_Tx87M&list=PLGTMA6Qkejfi6eXu5XGcdKlfe4dEsfVlt
The National Academy of Medicine (NAM) held an virtual event on August 17-20, 2020 named "The Critical Public Health Value of Vaccines - Tackling Issues of Access and Hesitancy". The event was conducted under the Forum of Microbial Threats of the National Academies of Sciences, Engineering, and Medicine. Note that Victor Dzau is the President of NAM and is a key stakeholder in Event 201. Dzau also serves as a member of China's CDC.
Panelists stated that doctors will be used to help increase vaccine confidence. One of the speeches was from Dorit Reiss, a pro-vax law Professor, who stated that the law could be used to promote compliance and access to vaccinations. https://www.youtube.com/watch?v=n96-yE6k_R8
Sponsors of the Forum:
Biomedical Advanced Research and Development Authority
U.S. Agency for International Development
U.S. Centers for Disease Control and Prevention
U.S. Department of Homeland Security
U.S. Department of Veterans Affairs
U.S. Food and Drug Administration
U.S. National Institutes of Health
Uniformed Services University of the Health Sciences
American Society of Tropical Medicine and Hygiene
EcoHealth Alliance
Infectious Diseases Society of America
Johnson & Johnson
Merck & Co., Inc.
Sanofi Pasteur
Event keynote speeches:
The Global Impact of COVID-19 on Vaccination Uptake and Access
ANN LINDSTRAND
EPI Coordinator, World Health Organization, Department of Immunization and Biologicals
The Global State of Vaccine Confidence: How Do We Enhance the Uptake of Vaccines?
SAAD B. OMER
Director, Yale Institute for Global Health
Event moderators:
-
Matthew Zahn, Orange County Health Care Agency, Workshop Co-Chair
-
Noni MacDonald, Dalhousie University
-
Alison Buttenheim, University of Pennsylvania
-
Chandy C. John, Indiana University School of Medicine
-
Rafael Obregon, UNICEF, Paraguay
-
Kent Kester, Sanofi Pasteur (Vice-Chair of the Forum on Microbial Threats)
-
Alison Buttenheim (University of Pennsylvania)
-
Amanda Cohn, U.S. Centers for Disease Control and Prevention
Planning committee included:
Amanda Cohn, M.D.
Executive Secretariat, Advisory Committee on Immunization Practices
Acting Chief Medical Officer, National Center for Immunization and Respiratory Diseases
U.S. Centers for Disease Control and Prevention
Walter Orenstein, M.D.
Professor, Emory University
Associate Director, Emory Vaccine Center
Director, Emory Vaccine Policy and Development
Heidi Larson, M.A., Ph.D. (Co-Chair)
Professor of Anthropology, Risk and Decision Science
London School of Hygiene & Tropical Medicine
Director, The Vaccine Confidence Project
Agenda:
>Session I: Improving Access and Closing the Global Immunization Gap
Objectives:
Assess the current state of vaccine-preventable diseases globally, delineating the key barriers to dissemination and uptake of vaccines.
Examine evidence-based strategies to improve access to vaccines and increase immunization coverage, globally and locally.
>Session II: Assessing Global and Local Drivers of Vaccine Hesitancy
Objectives:
Examine trends in hesitant attitudes toward vaccination and the impact on declining immunization rates.
Evaluate the complex determinants and drivers of vaccine uptake, including sociocultural factors that influence perceptions, attitudes, and behaviors towards vaccination.
Explore methods to monitor and measure vaccine hesitancy to better address concerns, and to sustain confidence in vaccination.
>Session III: Employing a Systems Approach to Building Confidence and Increasing Uptake
Objectives:
Explore opportunities in research, communication, legislation, and technology in influencing vaccine behavior, improving access, and building confidence in immunization practices.
Discuss how community-based approaches and strategies can effectively and ethically be employed to reduce vaccine hesitancy and increase vaccine confidence.
Session IV: Moving Forward: Optimizing the Utilization of Vaccines
Objectives:
Discuss the impact of vaccines in mitigating the effects of emerging threats during an outbreak.
Discuss approaches to strengthen public trust in science and public health programs.
Synthesize priority actions that could ensure that immunization programs reach the last mile.
>>10523161 (pb) on Walter Orenstein